UPDATE: ICZOOM to Present at Benchmark Company's Annual Investor Conference
Institutional investors interested in learning more about ICZOOM and the Company's compelling multi-year growth opportunities can register for a one-on-one or small group meeting on
About ICZOOM Group Inc.
ICZOOM Group Inc. (Nasdaq: IZM) is primarily engaged in sales of electronic component products to customers in
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "anticipate," "estimate," "plan," "project," "continuing," "ongoing," "expect," "we believe," "we intend," "may," "should," "will," "could" and similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the U.S. Securities and Exchange Commission.
View original content to download multimedia:https://www.prnewswire.com/news-releases/update-iczoom-to-present-at-benchmark-companys-annual-investor-conference-301986799.html
SOURCE ICZOOM
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mini PC Brand VZMORE Makes Global Debut at ShowStoppers @ IFA 2026, Bringing Advanced Thermal Innovation to Mini PCs
- Best New Meme Coin to Buy: MemeToro Targets Traders Looking Beyond Traditional Memecoin Hype
- Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
The Benchmark CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share